Dabigatran etexilate and risk of myocardial infarction, other cardiovascular events, major bleeding, and all-cause mortality: a systematic review and meta-analysis of randomized controlled trials.

J Am Heart Assoc · 2014 · PMC4309041 · PMID 24906369

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

of borderline significanceP =0.057so close (0.05 < p ≤ 0.1)

However, a trend toward an increased risk of MI (33%) was detected, which was of borderline significance ( P =0.057).

also in 2,624 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.